Dr. Zhiqiang Qin

Louisiana State University Health Science Center – New Orleans, USA

Email: zqin@lsuhsc.edu

Qualifications

2007  Ph.D., Shanghai Medical School of Fudan University, Microbiology

2002  B.Sc., Shanghai Medical School of Fudan University, Basic Medicine

Publications (Selected)

1. Defee M, Qin Z, Dai L, Isaacs JS and Parsons C. Interactions between Hsp90 and oncogenic viruses implications for viral cancer therapeutics. Am J Cancer Res 2011;1(6):763-722.
2. Qin Z, Dai L, Bratoeva M, Slomiany MG, Toole BP and Parsons C. Cooperative roles for emmprin and LYVE-1 in the regulation of chemoresistance for Primary Effusion Lymphoma. Leukemia (in press).
3. Defee M, Qin Z, Dai L, Toole BP, Isaacs JS and Parsons C. Extracellular Hsp90 serves as a co-factor for NF-κB activation and cellular pathogenesis induced by an oncogenic herpesvirus. Am J Cancer Res. 2011;1(5):686-699.
4. Qin Z, Dai L, Toole BP, Robertson E and Parsons C. Regulation of Nm23-H1 and cell invasiveness by Kaposi’s sarcoma-associated herpesvirus. Journal of Virology. 2011; 85(7):3596-3606.
5. Qin Z, Defee M, Isaacs JS and Parsons C. Extracellular Hsp90 serves as a co-factor for MAPK activation and latent viral gene expression during de novo infection by KSHV. Virology. 2010; 403(1): 92-102.
6. Qin Z, Dai L, Slomiany MG, Toole BP and Parsons C. Direct activation of emmprin and associated pathogenesis by an oncogenic herpesvirus. Cancer Res. 2010; 70(10): 3884-3889.
7. Qin Z, Freitas E, Sullivan R, Mohan S, Bacelieri R, Branch D, Romano M, Kearney P, Oates J, Plaisance K, Renne R, Kaleeba J and Parsons C. Upregulation of xCT by KSHV-encoded microRNAs facilitates KSHV dissemination and persistence in an environment of oxidative stress. PLoS Pathog. 2010; 6(1):e1000742.
8. Qin Z, Kearney P, Plaisance K and Parsons CH. Pivotal advance: Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded microRNA specifically induce IL-6 and IL-10 secretion by macrophages and monocytes. J Leukoc Biol. 2010; 87(1):25-34.
9. Qin Z, Yang L, Qu D, Molin S and Tolker-Nielsen T. Pseudomonas aeruginosa extracellular products inhibit staphylococcal growth, and disrupt established biofilms produced by Staphylococcus epidermidis. Microbiology. 2009; 155(7): 2148-2156.
10. Qin Z, Zhang JD, Hu YF, Chi QJ, Mortensen NP, Qu D, Molin S and Ulstrup J. Organic compounds inhibiting Staphylococcus epidermidis adhesion and biofilm formation. Ultramicroscopy. 2009; 109(8): 881-888.
11. Qin Z, Baoleri L, Yang L, Zhang J, Yang XM, Qu D, Jiang HL and Molin S. Anti-microbial activities of YycG histidine kinase inhibitors against Staphylococcus epidermidis biofilms. FEMS Microbiology Letters. 2007; 273(2): 149-156.
12. Qin Z, Ou YZ, Yang L, Zhu YL, Tolker-Nielsen T, Molin S and Qu D. Role of autolysin-mediated DNA-release in biofilm formation of Staphylococcus epidermidis. Microbiology. 2007; 153 (7): 2083-2092.
13. Qin Z, Yang XM, Yang L, Jiang j, Ou YZ, Molin S and Qu D. Formation and properties of in vitro biofilms of ica-negative Staphylococcus epidermidis clinical isolates. Journal of Medical Microbiology. 2007; 56 (1): 83-93.
14. Qin Z, Zhang J, Xu B, Chen LL, Wu Y, Yang XM, Shen X, Molin S, Danchin A, Jiang HL and Qu D. Structure-based discovery of inhibitors of the YycG histidine kinase: New chemical leads to combat Staphylococcus epidermidis infections. BMC Microbiology. 2006; 10 (6): 96.
15. Zhang YQ, Ren SX, Li HL, Wang YX, Fu G, Yang J, Qin Z, Miao YG, Wang WY, Chen RS, Shen Y, Chen Z, Yuan ZH, Zhao GP, Qu D, Danchin A and Wen YM. Genome-based analysis of virulence genes in a non-biofilm-forming Staphylococcus epidermidis strain (ATCC 12228). Mol Microbiol. 2003; 49(6): 1577-1593.
16. Defee M, Qin Z, Dai L, Isaacs JS and Parsons C. Interactions between Hsp90 and oncogenic viruses implications for viral cancer therapeutics. Am J Cancer Res 2011;1(6):763-722.

Profile Details

NULL